Drug Therapy
- We have a greater understanding of ‘cardiac syndrome X,’ but questions remain
A better understanding of angina due to ischemia and no obstructive coronary artery disease has led to recognition of coronary microvascular dysfunction in many of these patients.
- Revisiting the ‘great masquerader’
An HIV patient presents with scaly brown lesions on the palms and soles, mildly painful oral erosions, and a buzzing sound in the right ear for the past 20 days.
- Chest pain: The importance of serial ECGs
Repeat electrocardiograms in a 44-year-old man who presented with severe hypertension revealed de Winter and Wellens patterns.
- Ketogenic diets in the management of type 1 diabetes: Safe or safety concern?
A review of the potential risks and benefits for managing type 1 diabetes based on available evidence.
Coronary microvascular dysfunction: Considerations for diagnosis and treatmentA review of pathophysiology, considerations for invasive and noninvasive coronary function testing, management, and remaining knowledge gaps.
- Rapid cognitive decline and myoclonus in a 52-year-old woman
Symptoms also included confusion, blank staring, blurred vision, incoordination of the extremities, decreased verbal communication, and holding her left hand in a fist.
- Teriparatide: Label changes and identifying patients for long-term use
The changes leave clinicians with the challenge of identifying appropriate patients.
- An 86-year-old man with unexplained right-sided headache and vision loss
Steroid treatment for suspected giant cell arteritis brought no improvement in vision or headache severity.
- Autoimmune brain disease: Think before testing
Immune serologic tests are not specific for any defined clinical diagnosis and thus should not be used to drive therapeutic decisions.
- Antiobesity drug therapy: An individualized and comprehensive approach
As part of a comprehensive plan, these drugs can provide lasting obesity control and additional health benefits, including decreased cardiovascular risk.